Forte Biosciences, Inc. (FBRX)
76.99
0.00 (0.00%)
USD |
NASDAQ |
Sep 10, 16:00
Forte Biosciences Gross Profit (TTM) : -0.075M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.075M |
| March 31, 2026 | -0.07M |
| December 31, 2025 | -0.064M |
| September 30, 2025 | -0.055M |
| June 30, 2025 | -0.048M |
| March 31, 2025 | -0.043M |
| December 31, 2024 | -0.039M |
| September 30, 2024 | -0.035M |
| June 30, 2024 | -0.028M |
| March 31, 2024 | -0.018M |
| December 31, 2023 | -0.009M |
| September 30, 2023 | -0.003M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | -0.009M |
| March 31, 2022 | -0.022M |
| December 31, 2021 | -0.036M |
| September 30, 2021 | -0.05M |
| Date | Value |
|---|---|
| June 30, 2021 | -0.054M |
| March 31, 2021 | -0.041M |
| December 31, 2020 | -0.04M |
| September 30, 2020 | -0.026M |
| June 30, 2020 | -0.013M |
| March 31, 2020 | -0.013M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| argenx SE | 4.673B |
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Alnylam Pharmaceuticals, Inc. | 3.827B |
| Anika Therapeutics, Inc. | 75.00M |
| Savara, Inc. | -0.281M |